Need professional-grade analysis? Visit stockanalysis.com
$17.61M
N/A
N/A
N/A
Pathkey.ai Ltd (PKY) trades on Australian Securities Exchange in AUD. The company is classified in the Healthcare sector under the Health Information Services industry. The stock currently trades at AUD0.03.
Over the past year, PKY has traded between a low of AUD0.01 and a high of AUD0.03. The stock has gained 11.1% over this period. It is currently 6.3% below its 52-week high.
Pathkey.ai Ltd has a market capitalization of $17.61M.
Pathkey.AI Ltd, a digital health company, involves artificial intelligence (AI) to improve clinical trials and predicting outcomes for patients in Australia. The company offers TrialKey, an AI-driven clinical trial optimization and success prediction platform, that simulate and optimize trial designs. It also provides TrialGen, an AI-powered tool streamlines clinical trial design process. The company serves biopharma, MedTech, government, and healthcare organizations. The company was formerly known as Opyl Limited and changed its name to Pathkey.AI Ltd in August 2025. Pathkey.AI Ltd was incorporated in 1994 and is based in Sydney, Australia.
Side-by-side comparison against top Healthcare peers.